SKU: H027  / 
    CAS Number: 118-08-1

    Hydrastine, EvoPure®

    ₹13,425.80 - ₹43,342.64
    Hydrastine, EvoPure®
    • Detailed Description

      CAS Number: 118-08-1

      Molecular Formula: C21H21NO6

      Molecular Weight: 383.40

      Mechanism of Action: Hydrastine inhibits dopamine biosynthesis by inhibiting tyrosine hydroxylase activity. Its pharmacokinetics has not been adequately described.

      Storage Conditions: -20C

      Tariff Code: 2939.79.0000

    • Applications

      Spectrum: Effective against Gram-positive and Gram-negative bacteria.

      Eukaryotic Cell Culture Applications: Hydrastine decreases the basal intracellular Ca2+ concentration in PC12 cells. A concentration of 10-100 µM, when combined with high extracellular potassium level (56mM) inhibited dopamine release in a concentration-dependent manner. This suggests that the actives sites of Hydrastine are mainly L-type Ca2+ channels and caffeine-sensitive Ca2+-permeable channels (Yin et al, 2007).

    • Specifications

      Form: Powder

      Appearance: White to light yellow powder

      Source: Hydrastis canadensis

    • Technical Data

      Solubility: Soluble in acetone, DMF, or DMSO. Practically insoluble in water.

    • References

      References:

      Churchhill J (1862) The Pharmaceutical journal: A weekly Record of pharmacy and allied sciences. London. pp. 547

      Kim SH et al (2001) Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med. 67(7):609-6

      Yin SY et al (2007) Effects of (1R,9S)-beta-hydrastine on intracellular calcium concentration in PC12 cells. Biol. Pharm. Bull. 30(8):1547-1550 PMID 17666818

    Hydrastine, EvoPure® is a soquinoline alkaloid and an inhibitor of dopamine biosynthesis. It was discovered in 1851 by Alfred P Durand. It is a natural product from Hydrastis canadensis (goldenseal) and other plants of the ranunculaceae family. Hydrastine is converted to Hydrastinine via hydrolysis. Hydrastine is soluble in water.

    syn: (-)-β-Hydrastine, β-Hydrastine, (1R,9S)-β-Hydrastine

    EvoPure® products have been fully characterized by spectral analysis and are shipped with a comprehensive certificate of analysis containing lot-specific HPLC, MS, HNMR, and FTIR data.

    CAS Number: 118-08-1

    Molecular Formula: C21H21NO6

    Molecular Weight: 383.40

    Mechanism of Action: Hydrastine inhibits dopamine biosynthesis by inhibiting tyrosine hydroxylase activity. Its pharmacokinetics has not been adequately described.

    Storage Conditions: -20C

    Tariff Code: 2939.79.0000

    Spectrum: Effective against Gram-positive and Gram-negative bacteria.

    Eukaryotic Cell Culture Applications: Hydrastine decreases the basal intracellular Ca2+ concentration in PC12 cells. A concentration of 10-100 µM, when combined with high extracellular potassium level (56mM) inhibited dopamine release in a concentration-dependent manner. This suggests that the actives sites of Hydrastine are mainly L-type Ca2+ channels and caffeine-sensitive Ca2+-permeable channels (Yin et al, 2007).

    Form: Powder

    Appearance: White to light yellow powder

    Source: Hydrastis canadensis

    Solubility: Soluble in acetone, DMF, or DMSO. Practically insoluble in water.

    References:

    Churchhill J (1862) The Pharmaceutical journal: A weekly Record of pharmacy and allied sciences. London. pp. 547

    Kim SH et al (2001) Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med. 67(7):609-6

    Yin SY et al (2007) Effects of (1R,9S)-beta-hydrastine on intracellular calcium concentration in PC12 cells. Biol. Pharm. Bull. 30(8):1547-1550 PMID 17666818